Alcohol-associated liver disease
Supplements studied for alcohol-associated liver disease.
Overview
Only Alpha-Lipoic Acid is indexed for alcohol-associated liver disease, with one low-rated study (WA 32) for effect size and evidence and medium trust.
Oral alpha-lipoic acid at 300 mg daily for up to six months does not appear to improve liver function or reduce liver damage in people with liver disease caused by alcohol. The available trial found no benefit on these outcomes over the study period.
Evidence remains very limited to this single study. The evidence review below summarizes the trial in more detail.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
3 supplements for and rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in